DGX vs DVA
Quest Diagnostics (DGX) and DaVita (DVA) compared side by side. Quest Diagnostics (DGX) is larger, with a market cap of $26.7B versus $11.7B for DaVita, about 2.3 times the size. On trailing earnings, DVA is cheaper at 15.5x versus 24.1x for DGX.
Head to head
| Metric | DGX | DVA |
|---|---|---|
| Market cap | $26.7B | $11.7B |
| P/E (TTM) | 24.1x | 15.5x |
| Forward P/E | 20.2x | 10.7x |
| Revenue (TTM) | $11.8B | $14.0B |
| Revenue growth | 10.0% | 5.2% |
| Gross margin | 33.2% | 32.4% |
| Operating margin | 15.6% | 16.1% |
| Free cash flow | $1.3B | $1.6B |
| Dividend yield | 1.42% | None |
| 1-year return | +34.2% | +43.4% |
| 5-year return (annual) | +12.7% | +9.7% |
| Max drawdown | -49% | -93% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
DGX vs DVA FAQ
Which is bigger, DGX or DVA?
Quest Diagnostics (DGX) is larger, with a market cap of $26.7B versus $11.7B for DaVita, about 2.3 times the size.
Is DGX or DVA cheaper?
On trailing earnings, DVA is cheaper at 15.5x versus 24.1x for DGX. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, DGX or DVA?
DVA returned +43.4% over the past year including dividends, versus +34.2% for DGX, through October 23, 2026.
Which pays a higher dividend, DGX or DVA?
DGX yields 1.42%; DVA does not pay a dividend.
Full pages: Quest Diagnostics · DaVita